Vanessa Dumeaux

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study (2008)

Dumeaux, Vanessa, Børresen-Dale, Anne-Lise, Frantzen, Jan-Ole, Kumle, Merethe, Kristensen, Vessela N, Lund, Eiliv

Abstract Introduction The introduction of high-throughput technologies, also called -omics technologies, into epidemiology has raised the need for high-quality observational studies to reduce several...

Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort – a cross-sectional analysis (2008)

Waaseth, Marit, Bakken, Kjersti, Dumeaux, Vanessa, Olsen, Karina S, Rylander, Charlotta, Figenschau, Yngve, ...

Abstract Background Hormone replacement therapy use (HRT) is associated with increased breast cancer risk. Our primary objective was to explore hormone levels in plasma according to HRT use, body...

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. (2007)

Dumeaux, Vanessa, Fournier, Agnès, Lund, Eiliv, Clavel-Chapelon, Françoise

OBJECTIVE: To assess postmenopausal breast cancer risk in relation to particular patterns of oral contraceptive (OC) use according to hormone replacement therapy (HRT) exposure. METHODS:...

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. (2007)

Dumeaux, Vanessa, Fournier, Agnès, Lund, Eiliv, Clavel-Chapelon, Françoise

OBJECTIVE: To assess postmenopausal breast cancer risk in relation to particular patterns of oral contraceptive (OC) use according to hormone replacement therapy (HRT) exposure. METHODS:...

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1founder mutations; relation to age at diagnosis and survival (2005)

Kringen, Pedro, Wang, Yun, Dumeaux, Vanessa, Nesland, Jahn M, Kristensen, Gunnar, Borresen-Dale, Anne-Lise, ...

Abstract Background Ovarian carcinomas from 30 BRCA1 germ-line carriers of two distinct high penetrant founder mutations, 20 carrying the 1675delA and 10 the 1135insA, and 100 sporadic cases were...

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

Kringen, Pedro, Wang, Yun, Dumeaux, Vanessa, Nesland, Jahn M, Kristensen, Gunnar, Borresen-Dale, Anne-Lise, ...

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

Kringen, Pedro, Wang, Yun, Dumeaux, Vanessa, Nesland, Jahn M, Kristensen, Gunnar, Borresen-Dale, Anne-Lise, ...

Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort – a cross-sectional analysis

Waaseth, Marit, Bakken, Kjersti, Dumeaux, Vanessa, Olsen, Karina S, Rylander, Charlotta, Figenschau, Yngve, ...

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study

Dumeaux, Vanessa, Børresen-Dale, Anne-Lise, Frantzen, Jan-Ole, Kumle, Merethe, Kristensen, Vessela N, Lund, Eiliv